These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38030578)

  • 21. Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.
    Feih JT; Rinka JRG; Zundel MT
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1301-1307. PubMed ID: 30606508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxocobalamin in Refractory Septic Shock: A Retrospective Case Series.
    Sacco AJ; Cunningham CA; Kosiorek HE; Sen A
    Crit Care Explor; 2021 Apr; 3(4):e0408. PubMed ID: 33912838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.
    Malouf R; Grimley Evans J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004514. PubMed ID: 18843658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic vitamin B12 deficiency: a missed opportunity to prevent dementia and stroke.
    Spence JD
    Nutr Res; 2016 Feb; 36(2):109-16. PubMed ID: 26597770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxocobalamin Versus Methylene Blue for the Treatment of Vasoplegic Shock Associated With Cardiopulmonary Bypass.
    Hiruy A; Ciapala S; Donaldson C; Wang L; Hohlfelder B
    J Cardiothorac Vasc Anesth; 2023 Nov; 37(11):2228-2235. PubMed ID: 37586951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of vasopressin in the treatment of vasodilation in shock states.
    Rozenfeld V; Cheng JW
    Ann Pharmacother; 2000 Feb; 34(2):250-4. PubMed ID: 10676834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normalization of plasma vitamin B12 concentration by intranasal hydroxocobalamin in vitamin B12-deficient patients.
    Slot WB; Merkus FW; Van Deventer SJ; Tytgat GN
    Gastroenterology; 1997 Aug; 113(2):430-3. PubMed ID: 9247460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The Redox-Catalytic Properties of Cobalamins].
    Shatalin YV; Shubina VS; Solovieva ME; Akatov VS
    Mol Biol (Mosk); 2023; 57(6):1043-1057. PubMed ID: 38062959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials.
    Belletti A; Musu M; Silvetti S; Saleh O; Pasin L; Monaco F; Hajjar LA; Fominskiy E; Finco G; Zangrillo A; Landoni G
    PLoS One; 2015; 10(11):e0142605. PubMed ID: 26558621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of Refractory Vasodilatory Shock.
    Jentzer JC; Vallabhajosyula S; Khanna AK; Chawla LS; Busse LW; Kashani KB
    Chest; 2018 Aug; 154(2):416-426. PubMed ID: 29329694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended duration infusion of high-dose hydroxocobalamin for vasoplegic syndrome following cardiac surgery.
    Seelhammer TG; Plack D; Nei S; Wittwer E; Nelson J; Nabzdyk CGS
    Heart Lung; 2021; 50(2):173-176. PubMed ID: 33242823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methylene blue in the treatment of vasodilatory shock: a Meta-analysis].
    Zhang X; Gao Y; Pan P; Wang Y; Li W; Yu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Nov; 29(11):982-987. PubMed ID: 29151412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
    Serpa Neto A; Nassar AP; Cardoso SO; Manetta JA; Pereira VG; Espósito DC; Damasceno MC; Russell JA
    Crit Care; 2012 Aug; 16(4):R154. PubMed ID: 22889256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vitamin B12, an analgesic vitamin? Critical examination of the literature].
    Dordain G; Aumaitre O; Eschalier A; Decamps A
    Acta Neurol Belg; 1984; 84(1):5-11. PubMed ID: 6372359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of 8-week oral supplementation with 3-µg cyano-B12 or hydroxo-B12 in a vitamin B12-deficient population.
    Greibe E; Mahalle N; Bhide V; Fedosov S; Heegaard CW; Naik S; Nexo E
    Eur J Nutr; 2019 Feb; 58(1):261-270. PubMed ID: 29209773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vasopressin for treatment of shock].
    Carrillo-Esper R; Calvo-Carrillo B
    Cir Cir; 2003; 71(2):129-36. PubMed ID: 19764141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
    Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
    Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folic acid with or without vitamin B12 for cognition and dementia.
    Malouf M; Grimley EJ; Areosa SA
    Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.
    Dünser MW; Mayr AJ; Ulmer H; Knotzer H; Sumann G; Pajk W; Friesenecker B; Hasibeder WR
    Circulation; 2003 May; 107(18):2313-9. PubMed ID: 12732600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.